The global flow cytometry market is expected to witness a CAGR of ~9% during the forecast period. High incidence and ...
Accellix™, a pioneer in automated flow cytometry, and Streck, a recognized leader in quality control materials for flow ...
Bristol Myers Squibb (NYSE: BMY) today announced that the Phase 3 EXCALIBER-RRMM study evaluating iberdomide, an investigational cereblon E3 ligase modulator (CELMoD™), combined with standard ...
Years before people develop rheumatoid arthritis, their blood teems with activated immune cells that could serve as ...
After the presentation, a thrilling lottery session took place.
Becton Dickinson (NYSE: BDX) over the past quarter, offering a diverse set of opinions from bullish to bearish.
Heartflow has secured a new FDA clearance for its artificial intelligence program to analyze the buildup of dangerous plaques ...
Heartflow disclosed the clearance alongside news that Cigna has become the second national insurer after UnitedHealthcare to ...
LCGC International spoke to Maria Hayder, corresponding author of a recently published paper (1) discussing a novel workflow ...
The ALBORADA Drug Discovery Institute, University of Cambridge, Cambridge, United Kingdom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback